Recent Company News

• 08:19 AM ET Jul 01, 2025
  

  StreetAccount Summary - US Pre-market trading

• 04:51 PM ET Jun 30, 2025
  

  Follow-up: Legend Biotech comments on updated labeling for CARVYKTI following FDA update ($35.49, 0.00)

• 04:10 PM ET Jun 30, 2025
  

  Legend Biotech discloses updated warning requirement for CARVYKTI by the EMA - 6-K ($35.49, 0.00)

• 07:29 PM ET Jun 27, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 09:04 AM ET Jun 17, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:10 AM ET Jun 27, 2025
  

  FDA confirms REMS has been eliminated for approved BCMA- and CD19-directed CAR-T immunotherapies

• 09:29 AM ET Jun 20, 2025
  

  Gene therapy reviewer at FDA's CBER escorted out on Wednesday

• 07:31 AM ET Jun 11, 2025
  

  Legend Biotech Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Legend Biotech Corporation (LEGN)

• 07:32 AM ET Jun 10, 2025
  

  LEGN STOCK ALERT: Levi & Korsinsky Notifies Legend Biotech Corporation Investors of an Ongoing Investigation